BD (Becton, Dickinson and Company) Licenses Intellectual Property to Ivera Medical Corporation.SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. -- Ivera Medical Corporation, a San Diego (CA) based medical device company, today announced an exclusive license agreement with BD (Becton, Dickinson and Company), a global medical technology company, for the worldwide rights to selected BD-issued and pending patents for an intravenous (I.V.) port protector designed to reduce the potential for healthcare-acquired bloodstream blood·stream n. The flow of blood through the circulatory system of an organism. bloodstream the blood flowing through the circulatory system in the living body. infections. "This license agreement between our two companies confirms our mutual commitment to assist healthcare providers in their efforts to reduce bloodstream infections. We believe a significant number of these infections are caused by touch or airborne contamination of needleless I.V. ports," Bob Rogers
Healthcare-acquired bloodstream infections dramatically increase a patient's hospital length of stay, potential mortality and the overall cost of care, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. a recently released study by the Pennsylvania Health Care Cost Containment cost containment, n the features of a dental benefits program or of the administration of the program designed to reduce or eliminate certain charges to the plan. Council. Every year in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. alone healthcare-acquired bloodstream infections are estimated to cost the healthcare system over $5 billion. "The licensing agreement between BD and Ivera broadens our existing patent applications and removes potential patent issues so we can move forward with the worldwide marketing and sales of the Curos Port Protector," Jack Saladow, Ivera Vice President of Marketing and Sales said. "We are very pleased with this exclusive license from BD, and we are looking forward to the expansion of Ivera Medical's product offering," Rogers added. About Ivera Medical Corporation: Ivera Medical develops, manufactures and markets innovative, high quality medical devices to improve healthcare providers' management and control of patient infections. www.iveramedical.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion